Ceny
Vstoupit do systému
Search keywords: glucagon
Nalezeno obrázků: 2
Podle datumu přijetíPodle oblibenosti
Obrázků na stránce:
Obrázky z Adobe Stock
GLP letter logo design on black background. GLP creative initials letter logo concept. GLP letter design.
Futuristic hud banner that have word non compliance on user interface screen on blue background
The letter GCG is hexagon shape
Garvagliptin molecular structure, flat skeletal chemical formula. DPP4 inhibitor drug used to treat Diabetes type 2. Vector illustration.
GPP - Good Pharmacy Practices acronym, concept background
Antidiabetic drugs. Diabetes mellitus type 1, pancreas's failure to produce enough insulin and type 2, cells fail to respond to insulin (Insulin resistance). Result in high blood glucose levels.
Diabetes mellitus type 1, pancreas's failure to produce enough insulin. High blood glucose levels. Diagram illustration.
Diabetes mellitus type 2, cells fail to respond to insulin (Insulin resistance). high blood glucose levels. Vector Diagram illustration.
Miglitol molecular structure, flat skeletal chemical formula. Alpha-glucosidase inhibitor drug used to treat Diabetes type 2. Vector illustration.
Omarigliptin molecular structure, flat skeletal chemical formula. DPP4 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Red color inserted label with word non compliance on gray background
Rosglitazone molecular structure, flat skeletal chemical formula. Thiazolidinedione drug used to treat Diabetes type 2. Vector illustration.
Nateglinide molecular structure, flat skeletal chemical formula. Meglitinide drug used to treat Diabetes type 2. Vector illustration.
Acarbose molecular structure, flat skeletal chemical formula. Alpha-glucosidase inhibitor drug used to treat Diabetes type 2. Vector illustration.
Lobeglitazone molecular structure, flat skeletal chemical formula. Thiazolidinedione drug used to treat Diabetes type 2. Vector illustration.
Linagliptin molecular structure, flat skeletal chemical formula. DPP4 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Insulin mechanism of action, regulates glucose metabolism and glucose blood level. Insulin is the key that unlocks glucose channel. Insulin resistance. Vector illustration.
Envelope and letter sign with word compliance as the headline
Insulin mechanism of action, regulates glucose metabolism and glucose blood level. Insulin is the key that unlocks glucose channel. Insulin resistance. Vector illustration.
Evogliptin molecular structure, flat skeletal chemical formula. DPP4 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Carbutamide molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Repaglinide molecular structure, flat skeletal chemical formula. Meglitinide drug used to treat Diabetes type 2. Vector illustration.
Metformin molecular structure, flat skeletal chemical formula. Biguanide drug used to treat Diabetes type 2. Vector illustration.
Gliclazide molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Sorbinil molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Zenarestat molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Diabetes mellitus type 2, cells fail to respond to insulin (Insulin resistance). high blood glucose levels. Vector Diagram illustration.
Phospholipase C (PLC). Diacylglycerol (DAG) and Inositol 1,4,5 trisphosphate. Protein kinase C (PKC). Vector illustration.
Gemigliptin molecular structure, flat skeletal chemical formula. DPP4 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Darglitazone molecular structure, flat skeletal chemical formula. Thiazolidinedione drug used to treat Diabetes type 2. Vector illustration.
Rivoglitazone molecular structure, flat skeletal chemical formula. Thiazolidinedione drug used to treat Diabetes type 2. Vector illustration.
Voglibose molecular structure, flat skeletal chemical formula. Alpha-glucosidase inhibitor drug used to treat Diabetes type 2. Vector illustration.
Color megaphone icon with word non compliance in white banner on blue background
Tolbutamide molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Ranirestat molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Insulin, regulates glucose metabolism and glucose blood level. Insulin is the key that unlocks glucose channel. Type 1 diabetes Vector illustration.
Tolazamide molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Ripped gray paper background that have word calibration under torn part
Fidarestat molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Alrestatin molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Insulin mechanism of action, regulates glucose metabolism and glucose blood level. Insulin is the key that unlocks glucose channel. Insulin resistance. Vector illustration.
Acetohexamide molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Ponalrestat molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Diabetes mellitus type 1, pancreas's failure to produce enough insulin and type 2, cells fail to respond to insulin (Insulin resistance). Result in high blood glucose levels. Vector illustration.
Netoglitazone molecular structure, flat skeletal chemical formula. Thiazolidinedione drug used to treat Diabetes type 2. Vector illustration.
Glipizide molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Englitazone molecular structure, flat skeletal chemical formula. Thiazolidinedione drug used to treat Diabetes type 2. Vector illustration.
Futuristic hud banner that have word under validation on user interface screen on blue background
Tenegliptin molecular structure, flat skeletal chemical formula. DPP4 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Grunge red compliance word rubber seal stamp on white background
Aleglitazar molecular structure, flat skeletal chemical formula. Dual PPAR agonist drug used to treat Diabetes type 2. Vector illustration.
Mitiglinide molecular structure, flat skeletal chemical formula. Meglitinide drug used to treat Diabetes type 2. Vector illustration.
Diabetes mellitus type 1, pancreas's failure to produce enough insulin and type 2, cells fail to respond to insulin (Insulin resistance). Result in high blood glucose levels. Vector illustration.
Zopolrestat molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Tolrestat molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Diabetes mellitus type 2, cells fail to respond to insulin (Insulin resistance). high blood glucose levels. Vector Diagram illustration
Trelagliptin molecular structure, flat skeletal chemical formula. DPP4 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Phospholipase C (PLC). Diacylglycerol (DAG) and Inositol 1,4,5 trisphosphate. Protein kinase C (PKC). Vector illustration.
Torglitazone molecular structure, flat skeletal chemical formula. Thiazolidinedione drug used to treat Diabetes type 2. Vector illustration.
Diabetes mellitus type 1, pancreas's failure to produce enough insulin and type 2, cells fail to respond to insulin (Insulin resistance). Result in high blood glucose levels. Vector illustration
Remogliflozin molecular structure, flat skeletal chemical formula. SGLT2 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Muraglitazar molecular structure, flat skeletal chemical formula. Dual PPAR agonist drug used to treat Diabetes type 2. Vector illustration.
Ripped gray paper background that have word GLP (Abbreviation of Good laboratory practice) certified under torn part
Tesaglitazar molecular structure, flat skeletal chemical formula. Dual PPAR agonist drug used to treat Diabetes type 2. Vector illustration.
Sitagliptin molecular structure, flat skeletal chemical formula. DPP4 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Endocrine Icon
Chlorpropamide molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Green color of futuristic hud banner that have word non compliance on user interface screen on black background
Tofogliflozin molecular structure, flat skeletal chemical formula. SGLT2 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Sotagliflozin molecular structure, flat skeletal chemical formula. SGLT2 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Ripped gray paper background that have word compliance under torn part
Luseogliflozin molecular structure, flat skeletal chemical formula. SGLT2 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Diabetes mellitus type 1, pancreas's failure to produce enough insulin and type 2, cells fail to respond to insulin (Insulin resistance). Result in high blood glucose levels. Vector illustration
Blue and orange color ticket with word calibration and white copy space
Grunge green non compliance word square rubber seal stamp on white background
Pioglitazone molecular structure, flat skeletal chemical formula. Thiazolidinedione drug used to treat Diabetes type 2. Vector illustration.
Blue and orange color ticket with word compliance and white copy space
Ipragliflozin molecular structure, flat skeletal chemical formula. SGLT2 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Salfredin B11 molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Metahexamide molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Glycyclamide molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Vintage blue color ribbon banner with word ISO 17025 certified on white background
Red color inserted label with word compliance on gray background
Minalrestat molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Epalrestat molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Pancreas Icon
Glibornuride molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Grunge red compliance word rubber seal stamp on white background
Diabetes mellitus type 1, pancreas's failure to produce enough insulin and type 2, cells fail to respond to insulin (Insulin resistance). Result in high blood glucose levels. Vector illustration
Glycopyramide molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Insulin mechanism of action, regulates glucose metabolism and glucose blood level. Insulin is the key that unlocks glucose channel. Insulin resistance. Vector illustration.
Buformin molecular structure, flat skeletal chemical formula. Biguanide drug used to treat Diabetes type 2. Vector illustration.
Lidorestat molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Yellow and black color with line striped label banner with word non compliance
Grunge blue ISO 17025 certified round rubber stamp
Table of cAMP mediated cell response - GPCR Gs signalling. Hormone mediated liver, adipose, muscle, bone and kidney response.
Blue color of futuristic hud banner that have word calibration on user interface screen on black background
Ertugliflozin molecular structure, flat skeletal chemical formula. SGLT2 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Blue color of futuristic hud banner that have word compliance on user interface screen on black background
Black and gold color round label sticker with word calibrated on white background
Next page
/ 10
VectorGraphics
FAQ
CONTACT US
[email protected]
SUBSCRIBE
LANGUAGES
Facebook icon Instagram icon Behance icon Twitter icon
Our goal is to offer the best high-quality vector illustrations and graphics. VectorGraphics is a vibrant community of creative artists, providing royalty-free images. All contents are released under the VectorGraphics License, which makes them safe to use for private and commercial purposes. Over 20000 vector illustrations and high-resolution images brought to you by our community of artists. We hand-select every illustration and accept only the best.
VectorGraphics.io All rights reserved.
Právní informace TERMS and AGREEMENT